Cardiovascular Effects of GnRH Antagonists Compared With Agonists in Prostate Cancer-Reference-Cited by-同舟云学术

Cardiovascular Effects of GnRH Antagonists Compared With Agonists in Prostate Cancer

Published:2023-10 Issue:5 Volume:5 Page:613-624
ISSN:2666-0873
Container-title:JACC: CardioOncology
language:en
Short-container-title:JACC: CardioOncology

Author:

Nelson Adam J.^ORCID,Lopes Renato D.,Hong Hwanhee,Hua Kaiyuan,Slovin Susan,Tan Sean^ORCID,Nilsson Jan,Bhatt Deepak L.^ORCID,Goodman Shaun G.,Evans Christopher P.,Clarke Noel W.,Shore Neal D.,Margel David,Klotz Laurence H.,Tombal Bertrand,Leong Darryl P.^ORCID,Alexander John H.,Higano Celestia S.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Oncology

Reference30 articles.

1. Cardiovascular risk in men with prostate cancer: insights from the RADICAL PC study;Leong;J Urol,2020

2. A population-based study of cardiovascular disease mortality risk in US cancer patients;Sturgeon;Eur Heart J,2019

3. Effect of androgen deprivation therapy on metabolic complications and cardiovascular risk;Melloni;J Cardiovasc Transl Res,2020

4. Cardiovascular morbidity associated with gonadotropin releasing hormone agonists and an antagonist;Albertsen;Eur Urol,2014

5. Oral relugolix for androgen-deprivation therapy in advanced prostate cancer;Shore;N Engl J Med,2020

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patient Preferences for Attributes of Androgen Deprivation Therapies in Prostate Cancer: A Discrete Choice Experiment with Latent Class Analysis;Advances in Therapy;2024-08-21

2. Cardio-oncology in advanced prostate cancer;Frontiers in Oncology;2024-06-14

3. Cardiovascular risk in ADT recipients: does the type of ADT matter?;Prostate Cancer and Prostatic Diseases;2024-04-25

4. Cardiovascular disease risk assessment and multidisciplinary care in prostate cancer treatment with ADT: recommendations from the APMA PCCV expert network;World Journal of Urology;2024-03-14

5. Cardiovascular Toxicity During Advanced Prostate Cancer Treatment;JACC: CardioOncology;2023-10